why attend

The Joining FORCEs Conference is an international program which offers general sessions and workshops on topics of interest to any individual or family with a BRCA mutation or hereditary breast and ovarian cancer and to health care providers who serve this community. The conference covers a wide range of topics which encompass all aspects of the hereditary cancer experience.

Attendees of the Joining FORCEs conference include:

• People with a BRCA 1 or BRCA 2 mutation
• People with a strong family history of breast, ovarian, or other cancers
• Women who are at high risk for breast or ovarian cancer
• Breast cancer survivors and ovarian cancer survivors
• Women considering prophylactic mastectomy or oophorectomy to lower their risk for cancer
• Women who have undergone prophylactic mastectomy or oophorectomy
• Women interested in learning about reconstruction options after mastectomy
• Relatives of people with a BRCA mutation or family history of cancer
• Health care providers who care for high-risk individuals or people who carry a BRCA mutation
• Mental health care providers whose practice includes high-risk individuals or people who carry a BRCA mutation
• Patient advocates

Reasons to attend

• Hear updates from leading researchers on BRCA and hereditary cancer
• Learn about standard-of-care and cutting-edge options available for lowering cancer risk or for detecting cancer early
• Learn about all the options available for breast reconstruction after mastectomy and tips on insurance coverage for out-of-state procedures
• Learn strategies for coping with being high-risk and/or a carrier of a BRCA mutation and strategies for sharing risk information with family members
• Learn about ways to improve your quality of life while living with hereditary cancer or hereditary cancer risk
• Learn about clinical trials available for high-risk individuals or cancer survivors with hereditary cancer
• Meet and share experiences with other individuals who have faced hereditary cancer risk
• Learn about advocating and improving lives of people with BRCA or hereditary cancer risk

[Back to Top]